The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy

MLA

Amandine Decroos, et al. “The CML Experience to Elucidate the Role of Innate T-Cells as Effectors in the Control of Residual Cancer Cells and as Potential Targets for Cancer Therapy.” Frontiers in Immunology, vol. 15, Nov. 2024. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1473139.

APA

Amandine Decroos, Sarah Meddour, Marine Demoy, Nathalie Piccirilli, Philippe Rousselot, Franck E. Nicolini, Stéphanie Ragot, Jean-Marc Gombert, André Herbelin, Alice Barbarin, & Emilie Cayssials. (2024). The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1473139

Chicago

Amandine Decroos, Sarah Meddour, Marine Demoy, Nathalie Piccirilli, Philippe Rousselot, Franck E. Nicolini, Stéphanie Ragot, et al. 2024. “The CML Experience to Elucidate the Role of Innate T-Cells as Effectors in the Control of Residual Cancer Cells and as Potential Targets for Cancer Therapy.” Frontiers in Immunology 15 (November). doi:10.3389/fimmu.2024.1473139.